Acute myeloid leukaemia (in remission) Recruiting Phase 1 / 2 Trials for Methotrexate (DB00563)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03842696Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Unrelated Donor Blood and Marrow TransplantationPrevention